Skip to main content
REGULUS RESOURCES INC. logo

REGULUS RESOURCES INC. — Investor Relations & Filings

Ticker · REG ISIN · US75915M1311 LEI · 529900VQYPDBLVK5DL14 TSXV Mining and quarrying
Filings indexed 123 across all filing types
Latest filing 2026-04-01 Regulatory Filings
Country CA Canada
Listing TSXV REG

About REGULUS RESOURCES INC.

https://regulusresources.com/

Regulus Resources Inc. is a mineral exploration company primarily focused on the acquisition and advancement of large-scale projects. The company's flagship asset is the AntaKori copper-gold-silver project located in Northern Peru. Regulus has continuously advanced the AntaKori project through extensive drilling campaigns, including the completion of Phase 1 and the subsequent Phase 2 program, which have supported multiple resource estimate updates. Recent technical work includes reporting attractive copper extraction rates utilizing Nuton Bio-Leaching technology and ongoing development toward an Integrated Sulphide Project Resource Estimate. The company recently consolidated 100% ownership of the Colquirrumi Claims, strengthening its position at AntaKori. Regulus was formed in 2010 by the former management team of Antares Minerals Inc.

Recent filings

Filing Released Lang Actions
Other material contracts - English.pdf
Regulatory Filings Classification · 25% confidence The document is a detailed legal agreement setting out the terms of a shareholder rights plan (poison pill) between the corporation and its rights agent. It is not an AGM material, earnings release, management discussion, M&A announcement, or any of the other specified report types. It is not an announcement of a report, nor is it a proxy statement, dividend notice, or share buyback disclosure. No specific filing category exists for a standalone rights plan contract, so it defaults to the fallback Regulatory Filings category.
2026-04-01 English
Other material contracts - English.pdf
Regulatory Filings Classification · 65% confidence The document is a Shareholder Rights Plan Agreement (a poison pill plan) between the company and its rights agent. It is a standalone legal contract, not an earnings release, annual or interim report, or other standard financial disclosure. It does not announce a vote result, capital raise, merger bid, board change, or dividend, nor is it an investor presentation or ESG report. As it does not cleanly fit into any specific category, it falls into the fallback “Regulatory Filings” category (RNS).
2026-04-01 English
52-109FV1 - Certification of annual filings - CFO (E).pdf
Audit Report / Information Classification · 95% confidence The document is a 'Form 52-109FV1 Certification of Annual Filings', which is a regulatory requirement for venture issuers in Canada to certify the accuracy of their annual financial statements and MD&A. It is a standalone regulatory certification document rather than the annual report itself, and it does not fit into the other specific categories like AGM-R, 10-K, or ER. Given its nature as a mandatory regulatory filing for compliance, 'RNS' (Regulatory Filings) is the most appropriate classification. FY 2025
2026-01-29 English
52-109FV1 - Certification of annual filings - CEO (E).pdf
Audit Report / Information Classification · 95% confidence The document is a 'Form 52-109FV1 Certification of Annual Filings', which is a regulatory requirement for venture issuers in Canada to certify the accuracy of their annual financial statements and MD&A. Since this is a standalone regulatory certification document rather than the annual report itself or a general announcement, it falls under the category of regulatory filings. FY 2025
2026-01-29 English
Annual MD&A - English.pdf
Management Reports Classification · 100% confidence The document is explicitly titled 'Management's Discussion and Analysis' (MD&A) for the year ended September 30, 2025. It provides a detailed narrative explanation of the company's financial condition, business operations, significant events, and future outlook. This content aligns perfectly with the definition of a Management Report (MDA), which serves as the management's commentary on financial results and business trends.
2026-01-29 English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF
Regulatory Filings Classification · 95% confidence The document is a Form 13-502F1, which is a regulatory filing required by the Ontario Securities Commission (OSC) for reporting issuers to calculate and pay their annual participation fees. It is a specific regulatory compliance document detailing market capitalization and fee calculations. Since it does not fit into the specific categories like Annual Reports, Earnings Releases, or Proxy Statements, it falls under the 'Regulatory Filings' (RNS) category as the appropriate fallback for miscellaneous regulatory submissions.
2026-01-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.